More than 200 studies across the globe are being conducted in the hopes of developing a COVID-19 vaccine, half a dozen among which are in the final stages of human trials. It now has a provisional agreement with Japan, Germany, Norway and 70 other nations to procure COVID-19 vaccines through the facility for their populations. COVAX currently has nine COVID-19 vaccine candidates in its portfolio, employing a range of different technologies and scientific approaches. SERUM INSTITUTE OF INDIAAstraZeneca has expanded its agreement with Oxford Biomedica to mass-produce its COVID-19 vaccine, the cell therapy firm said on Tuesday. Later, Bangladesh’s Beximco Pharmaceuticals opened talks with Serum Institute to become the sole distributor of the vaccine in Bangladesh.

Source: bd News24 September 04, 2020 18:11 UTC